Back
Bcn
BCN
Biocon Ltd
(BIOCON)
Follow
FY2024 Announcement
View More
Back
Bcn
BCN
Biocon Ltd
(BIOCON)
Follow
FY2024 Announcement
Filing:
Announcement
Published on:
23 May '24
Financial Results Published
10 May '25
Earnings Call Recording
9 May '25
Investor Presentation
9 May '25
Q4 FY25 Results
8 May '25
Postal Ballot Notice
6 May '25
Yesintek Market Access
5 May '25
Record Date Announced
30 Apr '25
Commercial Paper Redemption
29 Apr '25
Positive CHMP Opinion
26 Apr '25
Commercial Papers Issued
22 Apr '25
Credit Rating Update
15 Apr '25
Yesafili Launch
15 Apr '25
Compliance Certificate
14 Apr '25
FDA Approval Received
10 Apr '25
SEBI Compliance Cert.
10 Apr '25
FDA Approval
10 Apr '25
Earnings Conference Call
2 Apr '25
CEO Departure
1 Apr '25
Disclosure Delay
29 Mar '25
Dividend Reminder
28 Mar '25
FDA Approval
24 Mar '25
Positive Study Results
7 Mar '25
Insulin Access Expansion
6 Mar '25
Investor Meeting
6 Mar '25
FDA Approvals
4 Mar '25
Graduation Celebration
4 Mar '25
20 Years Anniversary
28 Feb '25
Postal Ballot Notice
28 Feb '25
Product Launch
28 Feb '25
Regulatory Order
25 Feb '25
Biosimilar Launch
24 Feb '25
Biosimilar Approval
18 Feb '25
Record Date Intimation
17 Feb '25
Public Art Project
11 Feb '25
Investor Meet Scheduled
7 Feb '25
Investor Meeting
7 Feb '25
Earnings Call Transcript
7 Feb '25
Positive Study Results
6 Feb '25
Corporate Presentation
3 Feb '25
Financial Results Update
1 Feb '25
Penalty Notification
1 Feb '25
Biocon Acquisition Completed
31 Jan '25
Q3 FY 25 Call
31 Jan '25
Q3 FY25 Earnings Call
31 Jan '25
Amendment Approved
30 Jan '25
Management Change
30 Jan '25
Equity Acquisition
30 Jan '25
Q3FY25 Results
30 Jan '25
Commercial Paper Issue
29 Jan '25
Investor Meetings
28 Jan '25
ESG Score Update
27 Jan '25
Credit Rating Update
22 Jan '25
FDA Classification VAI
12 Jan '25
Investor Conference
9 Jan '25
Regulation Compliance
9 Jan '25
Investor Meeting
8 Jan '25
Anniversary Celebration
7 Jan '25
Product Approval
7 Jan '25
Earnings Call Scheduled
3 Jan '25
New Product Approval
2 Jan '25
Acquisition Completion
30 Dec '24
FDA Inspection Result
24 Dec '24
EU Approval Granted
24 Dec '24
Investor Meeting
18 Dec '24
Investor Meeting
17 Dec '24
Approval Recommendation
15 Dec '24
Award Recognition
14 Dec '24
Investor Meeting
11 Dec '24
Asia IP Elite Award
11 Dec '24
Share Sale Announcement
10 Dec '24
FDA Inspection Update
7 Dec '24
FDA Approval Granted
1 Dec '24
Founders Day Celebration
29 Nov '24
Investor Meeting
28 Nov '24
Diabetes Care Initiative
27 Nov '24
Investor Meetings
27 Nov '24
Investor Meeting
26 Nov '24
Credit Rating Reaffirmed
26 Nov '24
Investor Meeting
25 Nov '24
Investor Meeting
22 Nov '24
Investor Meeting
19 Nov '24
Investor Meeting
18 Nov '24
Placement Success
14 Nov '24
FDA Classification Update
10 Nov '24
Q2 FY25 Earnings
7 Nov '24
Investor Meet Scheduled
7 Nov '24
Investor Meeting
7 Nov '24
Financial Results Published
1 Nov '24
Earnings Call Recording
31 Oct '24
Q2 FY25 Earnings
30 Oct '24
Q2FY25 Results
30 Oct '24
FDA Facility Classification
30 Oct '24
Top Employer Ranking
28 Oct '24
Biocon Awarded Honor
25 Oct '24
Regulatory Compliance
14 Oct '24
Fundraising Announcement
9 Oct '24
Biosimilar Adoption Boost
8 Oct '24
Debt Refinancing
3 Oct '24
FDA Inspection Results
28 Sep '24
FDA Inspection Update
28 Sep '24
Partnership Announcement
26 Sep '24
Dermatology Data Presentation
25 Sep '24
Senior Notes Offering
24 Sep '24
Investor Meeting
23 Sep '24
Corporate Presentation Anno...
23 Sep '24
FDA Inspection Update
21 Sep '24
Investor Meeting
17 Sep '24
Investor Meeting
13 Sep '24
Investor Meeting
12 Sep '24
Investor Meeting
6 Sep '24
Investor Meeting
5 Sep '24
Lost Share Certificates
3 Sep '24
Investor Meeting
3 Sep '24
FDA Approval
1 Sep '24
GST Penalty Ordered
31 Aug '24
Credit Rating Update
30 Aug '24
FDA Approval Received
30 Aug '24
FDA Approval Received
30 Aug '24
Investor Meeting
29 Aug '24
Biosimilar Market Entry
29 Aug '24
Regulatory Penalty
28 Aug '24
Postal Ballot Notice
24 Aug '24
Share Certificate Update
23 Aug '24
Investor Meeting
23 Aug '24
Q1 FY25 Earnings Call
19 Aug '24
Corporate Presentation
19 Aug '24
Investor Meetings
18 Aug '24
Financial Results
10 Aug '24
Earnings Calls
10 Aug '24
Director Appointments
9 Aug '24
Financial Results Announcement
8 Aug '24
Notification
5 Aug '24
Inspection Completion
27 Jul '24
Notification
27 Jul '24
Director Cessation
25 Jul '24
Reminder Letter
19 Jul '24
Newspaper Advertisement
19 Jul '24
Certificate Submission
16 Jul '24
AGM Advertisement
4 Jul '24
Meeting Conducted
3 Jul '24
Dividend Tax Deduction
28 Jun '24
Meeting Conducted
28 Jun '24
Investor Presentation Release
27 Jun '24
Meeting Conducted
26 Jun '24
Company Statement
24 Jun '24
Notification
22 Jun '24
Meeting Conducted
20 Jun '24
GST Penalty Intimation
19 Jun '24
Meeting Conducted
19 Jun '24
Notification
15 Jun '24
Clarification
14 Jun '24
Share Certificates Lost
14 Jun '24
Meeting Conducted
13 Jun '24
Investor Conference
12 Jun '24
CFO Appointment
11 Jun '24
Institutional Meeting
6 Jun '24
Investor Meeting
4 Jun '24
Regulatory Action
31 May '24
Investor Meet
31 May '24
Meeting Conducted
31 May '24
Investor Conference
27 May '24
Meeting Schedule
27 May '24
Licensing and Supply Deal
24 May '24
Compliance Report Submission
23 May '24
Published Reminder Letter
23 May '24
Reminder for Unclaimed Divi...
23 May '24
Transcript
23 May '24
Meeting Conducted
23 May '24
Biocon Biologics FDA Approval
21 May '24
Financial Results Publication
19 May '24
Earnings Call
17 May '24
Financial Results Announcement
16 May '24
Board Meeting Outcomes
16 May '24
Press Release
13 May '24
Tax Penalty Announcement
1 May '24
Tax Penalty Notices
30 Apr '24
Compliance Certificate
29 Apr '24
Compliance Certificate
29 Apr '24
Merger of Equals
25 Apr '24
Meeting with Investors/Anal...
23 Apr '24
Approval in South Africa
20 Apr '24
Licensing Agreement
17 Apr '24
Meeting with Investors
17 Apr '24
Certificate Submission
15 Apr '24
Board Meeting and Conferenc...
10 Apr '24
Meeting Conducted
8 Apr '24
Meeting with Investors
2 Apr '24
Business Transfer Completed
2 Apr '24
Drug Approval
1 Apr '24
Approval for Diabetes Drug
27 Mar '24
Drug Approval
27 Mar '24
Meeting Conducted
25 Mar '24
Newspaper Publication
23 Mar '24
Regulatory Compliance
22 Mar '24
Meeting with Investors
21 Mar '24
Resignation Announcement
14 Mar '24
CFO Resignation
14 Mar '24
Business Transfer to Eris L...
14 Mar '24
Appointment Announcement
4 Mar '24
Biocon Biologics Canada Mar...
4 Mar '24
Biocon Biologics Agreement
29 Feb '24
FDA Inspection Announcement
29 Feb '24
Meeting with Investors
27 Feb '24
Meeting Conducted
23 Feb '24
Corporate Guarantee Issued
23 Feb '24
Regulatory Penalty
23 Feb '24
Investor Meeting
21 Feb '24
Meeting with Investor
20 Feb '24
Press Release
20 Feb '24
Earnings Calls
16 Feb '24
Meetings with Investors
13 Feb '24
Newspaper Advertisement
11 Feb '24
Earnings Calls
9 Feb '24
Investor Presentation
9 Feb '24
Partnership with Sandoz Aus...
9 Feb '24
FDA Response Letter
9 Feb '24
Financial Results Announcement
8 Feb '24
Personnel Changes
8 Feb '24
resignation
8 Feb '24
Investor Conference
8 Feb '24
Credit Rating Update
7 Feb '24
Investor Conference
7 Feb '24
FDA Approval
6 Feb '24
Recognition of Consensus Gu...
5 Feb '24
Reminder Letter
31 Jan '24
Certificate under Regulatio...
11 Jan '24
Meeting with Investors
11 Jan '24
Board Meeting and Conferenc...
10 Jan '24
Legal Dispute
29 Dec '23
Biocon Biologics Partners w...
22 Dec '23
Management Resignation
20 Dec '23
Graduation Day
19 Dec '23
Integration of Acquired Bio...
18 Dec '23
Clarification on API Business
15 Dec '23
Recognition Achieved
15 Dec '23
Meeting with Investors
14 Dec '23
Financing
13 Dec '23
Meeting Conducted with Inst...
12 Dec '23
Meeting Conducted
5 Dec '23
Conferences
30 Nov '23
Credit Rating Reaffirmation
30 Nov '23
Disinvestment - Biosimilar ...
30 Nov '23
Voting results on Postal Ba...
29 Nov '23
Meetings Conducted
27 Nov '23
Meetings with Investors/Ana...
22 Nov '23
Earnings Calls
20 Nov '23
Meeting with Institutional ...
20 Nov '23
Investor Presentation
17 Nov '23
Investor Meetings
17 Nov '23
FDA Approval
13 Nov '23
Share Certificate Loss
11 Nov '23
Announcement
11 Nov '23
Presentation and Video Reco...
11 Nov '23
Related Party Transactions ...
10 Nov '23
Financial Results
10 Nov '23
Management Changes
10 Nov '23
Divestiture of Business
10 Nov '23
Divestment of Assets
10 Nov '23
Divestment of Business Units
8 Nov '23
Divestment of Business Units
8 Nov '23
Ranking in Science Magazine...
31 Oct '23
Advertisement
28 Oct '23
Finance Leadership Update
19 Oct '23
FDA Inspection Update
18 Oct '23
Certificate under Reg. 74 (...
16 Oct '23
Updated Meeting Schedule
13 Oct '23
Meeting Schedule
11 Oct '23
Investor Meeting
11 Oct '23
Change in Management
9 Oct '23
Board Meeting and Conferenc...
9 Oct '23
Dispute with US FDA
7 Oct '23
Partnership Agreement
6 Oct '23
Schedule Announcement
22 Sep '23
Penalty Imposed
22 Sep '23
Investor Meeting
22 Sep '23
Approval
20 Sep '23
Appointment
18 Sep '23
Appointment of CEO
18 Sep '23
Resignation of Director
18 Sep '23
Investor Meeting
13 Sep '23
Appointment
7 Sep '23
Expansion of Global Footprint
6 Sep '23
Acquisition of manufacturin...
1 Sep '23
Appointment of Director
1 Sep '23
Meeting with Institutional ...
31 Aug '23
Insider Trading Violations
25 Aug '23
Meeting with Investors
25 Aug '23
Meetings with Institutional...
24 Aug '23
Civil, Criminal Litigations
21 Aug '23
Financial Statements
21 Aug '23
Meetings with Analysts/Inst...
14 Aug '23
Financial Statements
12 Aug '23
Appointments, Re-appointments
11 Aug '23
Financial Statements
11 Aug '23
Presentation
11 Aug '23
Financial Statements
10 Aug '23
Financial Statements
10 Aug '23
Appointments
10 Aug '23
Workshop on Cities and Clim...
10 Aug '23
Announcement
5 Aug '23
Appointments
4 Aug '23
Financial Statements
29 Jul '23
Announcement
28 Jul '23
Management Changes
27 Jul '23
Appointments
26 Jul '23
Resignations
26 Jul '23
Appointments
26 Jul '23
Equity, Debt, VC, Private E...
24 Jul '23
Announcement
21 Jul '23
Financial Statements
21 Jul '23
Financial Statements
21 Jul '23
Financial Statements
18 Jul '23
Equity Offerings
12 Jul '23
Dividend Tax Deduction
10 Jul '23
Meeting with Institutional ...
6 Jul '23
Equity, Debt, VC, Private E...
5 Jul '23
Meetings with Institutional...
4 Jul '23
New Product Launches
3 Jul '23
Sustainability Initiatives
30 Jun '23
In-person meeting
26 Jun '23
Meeting Conducted
23 Jun '23
Postal Ballot Notice and Re...
21 Jun '23
Meeting with Analysts/Insti...
20 Jun '23
Meeting Conducted
15 Jun '23
Meetings with Institutional...
13 Jun '23
Investment in API manufactu...
8 Jun '23
Meetings conducted with Ins...
8 Jun '23
Meeting with Investors and ...
7 Jun '23
No observations
3 Jun '23
Meetings with Investors/Res...
2 Jun '23
Earnings Call Transcript
31 May '23
Meeting held with Investor/...
31 May '23
Disclosure of Related Party...
26 May '23
Financial Results Publication
25 May '23
Annual Secretarial Complian...
25 May '23
Virtual Meetings
25 May '23
Earnings Calls
24 May '23
Financial Statements
24 May '23
Spin-offs
23 May '23
Financial Results
23 May '23
Pre-Market Approval
20 May '23
Debt
19 May '23
n/a
16 May '23
Earnings Call
16 May '23
External Links:
BSE
NSE
Data:
Download
AI Assistant
Close
Biocon Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.
BIOCON Biocon Ltd Other Situations Announcement